Post by 3D-Side

In ankle arthroplasty, the question is no longer just: which implant? It is becoming: which workflow around the implant?   Building an in-house planning platform means years of development, regulatory submissions, clinical validation, and operational infrastructure before the first case. Few manufacturers have the resources to absorb that timeline while continuing to develop their implant portfolio.   Licensing an off-the-shelf solution solves the short-term problem but creates another tension. Integrating generic software into an implant portfolio often multiplies friction points: measurement conventions that do not align, workflow steps that do not match the protocol and an interface designed for a different implant.   The third option is a technology partner who builds the platform around your implant: component libraries configured to your specifications, alignment algorithms calibrated to your surgical philosophy, design and manufacturing of surgical guides within your regulatory framework. For the surgeon, the planning reflects exactly the implant in their hands: its geometry, its landmarks, its protocol.   That is what we do at 3D-Side, with an established regulatory framework (FDA 510(k), CE marking, ISO 13485) and manufacturing on both sides of the Atlantic.   Built around the manufacturer, at the service of the surgeon.   #AnkleArthroplasty #PatientSpecific #ImplantManufacturers

Video Content